Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by
significant morbidity and mortality, poor functional capacity and quality of life, and high costs …

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of 64
million people globally. Although the incidence of HF has stabilised worldwide and seems to …

Heart failure (HF) is a heterogeneous clinical syndrome marked by substantial morbidity and
mortality. The natural history of HF is well established; however, epidemiological data are …

Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is
increasing in prevalence. HF health expenditures are considerable and will increase …

Sarcopenia (loss of muscle mass and muscle function) is a strong predictor of frailty,
disability and mortality in older persons and may also occur in obese subjects. The …

Aims Sarcopenia, one of the extracardiac factors for reduced functional capacity and poor
outcome in heart failure (HF), may act differently between HF with preserved ejection fraction …

Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with
preserved ejection fraction (HFpEF) has traditionally received less attention than its main …

Patients suffering from chronic heart failure (CHF) show an increased prevalence (~ 20% in
elderly CHF patients) of loss of muscle mass and muscle function (ie sarcopenia) compared …

Background: In the Prospective Comparison of angiotensin receptor neprilysin inhibitor
(ARNI) With ACEi to Determine Impact on Global Mortality and Morbidity in Heart Failure …

Background The prevalence of iron deficiency (ID) in outpatients with heart failure with
preserved ejection fraction (HFpEF) and its relation to exercise capacity and quality of life …